银杏叶提取物治疗急性脑梗死36例疗效观察

The clinical observation on Ginkgo biloba extract in the treatment of 36 cases of acute cerebral infarction

目的观察银杏叶提取物(EGb)对脑梗死的治疗效果。方法脑梗死患者随机分为治疗组(36例)和对照组(36例)。对照组行常规治疗;治疗组在常规治疗基础上加用银杏叶提取物治疗。观察治疗前后的神经功能缺损评分变化及临床疗效,并与对照组比较。结果银杏叶提取物治疗组总有效率94.44%(3436),对照组总有效率69.44%(2536),2组比较差异有显著意义(P<0.05)。治疗组治疗前后神经功能缺损评分别为(20.86±1.15)和(11.65±1.08),差异有显著意义(P<0.05);对照组治疗前后神经功能缺损评分别为(21.13±1.11)和(15.74±0.88),差异有显著意义(P<0.05)。且治疗组与对照组治疗后比较,差异有显著意义(P<0.05)。结论银杏叶提取物对脑梗死疗效明显。

Objective To observe the clinical efficacy of Ginkgo biloba extract （EGb） in the treatment of cerebral infarction. Methods Patients with cerebral infarction were divided into two groups randomly, treatment group （n = 36） and control group （ n = 36）. The patients in control group were treated with routine drugs, however, the patients in treatment group, on the basis of routine therapy, were treated with Ginkgo biloba extract, the neural function defect score and clinical efficacy before and after treatment were observed and compared with those of control group. Results The total effective rates in EGb treatment group and control group were 94.44% （34/36） and 69.44% （25/ 36） respectively, there was a significant difference between the two groups （ P 〈 0.05）. The neural function defect score before and after treatment in EGb group was （20.86± 1.15） and （ 11.65 ± 1.08） respectively,while in control group which was （21.13 ± 1.11 ） and （ 15.74 ± 0.88）, there were significant differences in both groups before and after treatment （ P 〈 0.05） .The neural function defect score of patients in treatment group were significantly improved after treatment, as compared with those in control group （ P 〈 0.05）. Conclusion The Ginkgo biloba extract is effective in treating acute cerebral infarction.